Global Blood Plasma Market Growth 2023-2029
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
LPI (LP Information)' newest research report, the “Blood Plasma Industry Forecast” looks at past sales and reviews total world Blood Plasma sales in 2022, providing a comprehensive analysis by region and market sector of projected Blood Plasma sales for 2023 through 2029. With Blood Plasma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Plasma industry.
This Insight Report provides a comprehensive analysis of the global Blood Plasma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Plasma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Blood Plasma market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Plasma and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Plasma.
The global Blood Plasma market size is projected to grow from US$ 397.9 million in 2022 to US$ 469.6 million in 2029; it is expected to grow at a CAGR of 469.6 from 2023 to 2029.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Plasma market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Immunoglobulin
Albumin
Protease Inhibitors
Coagulation Factor Concentrates
Others
Segmentation by application
Hospitals and Clinics
Research Laboratories
Academic Institutions
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Baxter International
CSL
Grifols
Octapharma
ADMA Biologics
Cerus Corp
Sanquin
Shanghai Raas
TCS Biosciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Blood Plasma market?
What factors are driving Blood Plasma market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood Plasma market opportunities vary by end market size?
How does Blood Plasma break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.